MedTrace Logo

Assessment of Ergonomics in 3D vs 2D Thoracoscopic Lobectomy

NCT03925103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-04-08

No results posted yet for this study

Summary

Video-assisted thoracic surgery (VATS) pulmonary lobectomy is currently widely employed as the first treatment option for surgical management of early stage (stage I-II) non-small-cell-lung-cancer (NSCLC).

Thanks to recent technological advances in high definition display systems, three dimensional VATS (3D) has been developed in an attempt of overcoming some optical limits of two dimensional (2D) VATS.

In this single center randomized trial our aim is to comparatively assess ergonomics of 3D versus 2D VATS lobectomy for early stage NSCLC.

Conditions

  • Early Stage Non-small-cell Lung Cancer (Stage 1-2)

Interventions

PROCEDURE

3D VATS lobectomy

pulmonary lobectomy carried out by video-assisted thoracoscopic surgery with a 3 dimensional display system

PROCEDURE

2D VATS lobectomy

pulmonary lobectomy carried out by video-assisted thoracoscopic surgery with a 2 dimensional display system

Sponsors & Collaborators

  • University of Rome Tor Vergata

    lead OTHER

Principal Investigators

  • Eugenio Pompeo, MD · Tor Vergata University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925103 on ClinicalTrials.gov